AQR Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-68,195
| Closed | -$1.63M | – | 2218 |
|
|
2019
Q4 | $1.63M | Buy |
68,195
+9,393
| +16% | +$224K | ﹤0.01% | 1343 |
|
|
2019
Q3 | $1.58M | Buy |
58,802
+2,567
| +5% | +$68.8K | ﹤0.01% | 1370 |
|
|
2019
Q2 | $1.53M | Hold |
56,235
| – | – | ﹤0.01% | 1351 |
|
|
2019
Q1 | $1.95M | Buy |
56,235
+3,832
| +7% | +$133K | ﹤0.01% | 1324 |
|
|
2018
Q4 | $1.02M | Hold |
52,403
| – | – | ﹤0.01% | 1503 |
|
|
2018
Q3 | $1.4M | Buy |
52,403
+1,447
| +3% | +$38.5K | ﹤0.01% | 1560 |
|
|
2018
Q2 | $1.93M | Sell |
50,956
-26,241
| -34% | -$991K | ﹤0.01% | 1436 |
|
|
2018
Q1 | $2.52M | Sell |
77,197
-2,914
| -4% | -$95.2K | ﹤0.01% | 1253 |
|
|
2017
Q4 | $3.9M | Sell |
80,111
-1,694
| -2% | -$82.5K | ﹤0.01% | 1121 |
|
|
2017
Q3 | $4.42M | Buy |
81,805
+19,418
| +31% | +$1.05M | 0.01% | 1067 |
|
|
2017
Q2 | $3.5M | Buy |
62,387
+27,572
| +79% | +$1.55M | ﹤0.01% | 1168 |
|
|
2017
Q1 | $1.36M | Buy |
+34,815
| New | +$1.36M | ﹤0.01% | 1552 |
|
|
2016
Q2 | – | Sell |
-22,397
| Closed | -$457K | – | 2296 |
|
|
2016
Q1 | $457K | Sell |
22,397
-17,737
| -44% | -$362K | ﹤0.01% | 1870 |
|
|
2015
Q4 | $2.07M | Buy |
40,134
+2,234
| +6% | +$115K | ﹤0.01% | 1222 |
|
|
2015
Q3 | $1.62M | Sell |
37,900
-1,656
| -4% | -$70.6K | ﹤0.01% | 1228 |
|
|
2015
Q2 | $1.8M | Buy |
39,556
+33,356
| +538% | +$1.52M | ﹤0.01% | 1224 |
|
|
2015
Q1 | $235K | Buy |
+6,200
| New | +$235K | ﹤0.01% | 1965 |
|
|
2013
Q4 | – | Sell |
-19,500
| Closed | -$522K | – | 2624 |
|
|
2013
Q3 | $522K | Buy |
+19,500
| New | +$522K | ﹤0.01% | 1958 |
|